321 related articles for article (PubMed ID: 23639699)
1. D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.
Mori T; Kabashima K; Fukamachi S; Kuroda E; Sakabe J; Kobayashi M; Nakajima S; Nakano K; Tanaka Y; Matsushita S; Nakamura M; Tokura Y
J Dermatol Sci; 2013 Jul; 71(1):37-44. PubMed ID: 23639699
[TBL] [Abstract][Full Text] [Related]
2. Roles of dopamine receptor subtypes in mediating modulation of T lymphocyte function.
Huang Y; Qiu AW; Peng YP; Liu Y; Huang HW; Qiu YH
Neuro Endocrinol Lett; 2010; 31(6):782-91. PubMed ID: 21196914
[TBL] [Abstract][Full Text] [Related]
3. Tryptanthrin inhibits Th2 development, and IgE-mediated degranulation and IL-4 production by rat basophilic leukemia RBL-2H3 cells.
Iwaki K; Ohashi E; Arai N; Kohno K; Ushio S; Taniguchi M; Fukuda S
J Ethnopharmacol; 2011 Mar; 134(2):450-9. PubMed ID: 21216280
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
[TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid acetate inhibits atopic dermatitis and allergic contact dermatitis in a murine model.
Choi JK; Oh HM; Lee S; Park JW; Khang D; Lee SW; Lee WS; Rho MC; Kim SH
Toxicol Appl Pharmacol; 2013 May; 269(1):72-80. PubMed ID: 23499868
[TBL] [Abstract][Full Text] [Related]
6. Vitamin A deficiency exacerbates extrinsic atopic dermatitis development by potentiating type 2 helper T cell-type inflammation and mast cell activation.
Yang H; Chen JS; Zou WJ; Tan Q; Xiao YZ; Luo XY; Gao P; Fu Z; Wang H
Clin Exp Allergy; 2020 Aug; 50(8):942-953. PubMed ID: 32559330
[TBL] [Abstract][Full Text] [Related]
7. Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice.
Watcharanurak K; Nishikawa M; Takahashi Y; Kabashima K; Takahashi R; Takakura Y
Gene Ther; 2013 May; 20(5):538-44. PubMed ID: 22914497
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Trichophyton antigen-induced contact hypersensitivity in mouse.
Nakamura T; Nishibu A; Yasoshima M; Tanoue C; Yoshida N; Hatta J; Miyamoto T; Nishii M; Yanagibashi T; Nagai Y; Takatsu K; Mochizuki T; Ogawa K
J Dermatol Sci; 2012 May; 66(2):144-53. PubMed ID: 22459756
[TBL] [Abstract][Full Text] [Related]
9. Alternative therapeutic advantages of catfish bile on atopic dermatitis: protection of T cell-mediated skin disease via antioxidant activities.
Lee DI; Huh YJ; Hwang KW; Choi Y; Choi JS; Han SY; Gyoung YS; Joo SS
J Pharm Pharmacol; 2011 Oct; 63(10):1327-35. PubMed ID: 21899549
[TBL] [Abstract][Full Text] [Related]
10. Diversion of CD4+ T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response.
DiIulio NA; Xu H; Fairchild RL
Eur J Immunol; 1996 Nov; 26(11):2606-12. PubMed ID: 8921946
[TBL] [Abstract][Full Text] [Related]
11. Topical application of Pleurotus eryngii extracts inhibits 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice by the regulation of Th1/Th2 balance.
Choi JH; Kim HG; Jin SW; Han EH; Khanal T; Do MT; Hwang YP; Choi JM; Chun SS; Chung YC; Jeong TC; Jeong HG
Food Chem Toxicol; 2013 Mar; 53():38-45. PubMed ID: 23200891
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions.
Ohmen JD; Hanifin JM; Nickoloff BJ; Rea TH; Wyzykowski R; Kim J; Jullien D; McHugh T; Nassif AS; Chan SC
J Immunol; 1995 Feb; 154(4):1956-63. PubMed ID: 7836775
[TBL] [Abstract][Full Text] [Related]
13. Dopamine D1-like receptor antagonist attenuates Th17-mediated immune response and ovalbumin antigen-induced neutrophilic airway inflammation.
Nakagome K; Imamura M; Okada H; Kawahata K; Inoue T; Hashimoto K; Harada H; Higashi T; Takagi R; Nakano K; Hagiwara K; Kanazawa M; Dohi M; Nagata M; Matsushita S
J Immunol; 2011 May; 186(10):5975-82. PubMed ID: 21471450
[TBL] [Abstract][Full Text] [Related]
14. Dopamine induces IL-6-dependent IL-17 production via D1-like receptor on CD4 naive T cells and D1-like receptor antagonist SCH-23390 inhibits cartilage destruction in a human rheumatoid arthritis/SCID mouse chimera model.
Nakano K; Yamaoka K; Hanami K; Saito K; Sasaguri Y; Yanagihara N; Tanaka S; Katsuki I; Matsushita S; Tanaka Y
J Immunol; 2011 Mar; 186(6):3745-52. PubMed ID: 21307293
[TBL] [Abstract][Full Text] [Related]
15. CCL17 transgenic mice show an enhanced Th2-type response to both allergic and non-allergic stimuli.
Tsunemi Y; Saeki H; Nakamura K; Nagakubo D; Nakayama T; Yoshie O; Kagami S; Shimazu K; Kadono T; Sugaya M; Komine M; Matsushima K; Tamaki K
Eur J Immunol; 2006 Aug; 36(8):2116-27. PubMed ID: 16856206
[TBL] [Abstract][Full Text] [Related]
16. Induction of eosinophil- and Th2-attracting epidermal chemokines and cutaneous late-phase reaction in tape-stripped skin.
Onoue A; Kabashima K; Kobayashi M; Mori T; Tokura Y
Exp Dermatol; 2009 Dec; 18(12):1036-43. PubMed ID: 19558500
[TBL] [Abstract][Full Text] [Related]
17. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
[TBL] [Abstract][Full Text] [Related]
18. Phenylbutyrate suppresses distinct skin reactions that are enhanced by blockade of epidermal growth factor receptor signaling.
Chung YL; Pui NN
J Dermatol Sci; 2011 Dec; 64(3):163-73. PubMed ID: 21924869
[TBL] [Abstract][Full Text] [Related]
19. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
20. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5.
Murakami T; Yamanaka K; Tokime K; Kurokawa I; Tsutsui H; Nakanishi K; Mizutani H
Br J Dermatol; 2006 Jul; 155(1):27-32. PubMed ID: 16792748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
